Mixed connective tissue disease (MCTD) manifests as a number of cardiovascular diseases; however, myocardial infarction secondary to coronary artery disease has not been well documented. We present a case of a teenager with MCTD and known cardiac risk factors who developed an acute coronary syndrome.
Introduction
Coronary artery disease (CAD) is most commonly due to atherosclerosis. In addition to the usual risk factors that are associated with atherosclerosis (hyperlipidemia, hypertension, smoking, diabetes mellitus), in ammation has been recognized as being important in its pathogenesis. 1, 2 Other less common diseases may cause CAD, such as giant cell arteritis, Takayasu's arteritis, K awasaki's disease, as well as connective tissue diseases such as systemic lupus erythematosus and rheumatoid arthritis. 3¡6 It is likely that vascular in ammation plays a primary role in the pathogenesis of CAD in patients with these conditions. 1,2 M ixed connective tissue disease (MCTD) manifests as a number of cardiovascular diseases; however, myocardial infarction secondary to CAD has not been well documented. We present a case of a teenager with MCTD and known cardiac risk factors who developed an acute coronary syndrome. year-old African-American woman presented to the Mount Sinai Medical Center emergency department with the chief complaint of chest pain. She noticed sudden onset of sharp substernal chest pain at rest. Three days prior to the onset of symptoms, she had intermittent burning sensations in her left arm and chest after walking four blocks. She denied any associated symptoms such as dyspnea, palpitations, fever, or chills. The chest discomfort persisted for 4 h prior to her presentation to the emergency department.
Case report
Signi cant past medical history included MCTD that was diagnosed at the age of 11 years after the patient developed knee arthritis, Raynaud's phenomenon, and a positive extractable nuclear antibody (ENA) to ribonuclear protein (R NP). Other serologies were negative for dsDNA, Scl-70, anti-Ro and anti-La antibodies, and anti-Sm (Smith). The patient had an ANA level > 1:160 (speckled), and low C3 and C4 complement levels (41, normal; 88¡201 mg=dl; 10, normal: 16¡47 mg=dl, respectively).
The patient also had a past medical history of hypertension (as high as 210=140 mmHg), which was dif cult to control secondary to medical noncompliance. She underwent an evaluation for renovascular hypertension which included a normal duplex renal artery ultrasound. She was strongly encouraged to take multiple agents including labetolol, nifedipine, and furosemide to control her blood pressure.
In 1998, she experienced headaches with right-sided numbness and was found on head CT to have an acute left thalamic infarct, as well as multiple old infarcts. G iven her history of MCTD, the presumed etiology for her stroke was cerebral vasculitis and she was treated with prednisone and ve monthly cycles of cyclophosphamide. H er immunosuppressive treatment was tapered and completed after 1
year. An evaluation for hypercoagulopathy was negative for anticardiolipin antibodies, lupus anticoagulant, protein C and S de ciency, and homocystinemia.
In 1999, the patient was diagnosed with diabetes mellitus and started on subcutaneous insulin. She denied any use of alcohol, smoking or illicit drugs. There was no family history of premature coronary or cerebrovascular disease.
Examination revealed a weight of 69 kg (BMI: 30). The heart rate was 90 beats per minute and the brachial blood pressure was 133=80 mmH g and was equal in both arms. She had a normal heart exam with no evidence of pericardial rubs or heart murmurs. There were no carotid or abdominal bruits.
Laboratory investigation revealed a creatinine of 0.5 mg=dl, an initial creatinine kinase (CK ) of 153 U=l (normal: 25¡145 U =l) with a CK-M B of 6.0 U=l (normal: 5.7¡16.6 U=l), and a troponin-I of 1.2 ng=ml (normal:
The Zena and Michael A Wiener Cardiovascu lar Institute, The M ount Sinai School of M edicine, New York, N Y, USA 0.4¡2.0 ng=ml). C-reactive protein (CRP) was < 0.1 mg=dl (normal: 0.0¡0.8 mg=dl) and an erythrocyte sedimentation rate (ESR ) was elevated to 80 mm=h. The chest X-ray was negative for in ltrate, edema, or widened mediastinum, and the electrocardiogram notably demonstrated 2¡3 mm ST segment elevation in anteroseptal leads (V1-3).
The patient was initially started on intravenous metoprolol, heparin, nitroglycerin, and aspirin. After the ndings on electrocardiogram, IV integrilin was started in addition to the heparin in anticipation of percutaneous coronary intervention. Immediately after the initiation of treatment, her chest pain symptoms resolved. A bedside echocardiogram was performed which revealed a noncontractile mid and apical anteroseptal wall with mild to moderate decreased left ventricular function. Cardiac catheterization showed a 90¡95% mid left anterior descending artery and 80¡90% left posterior lateral artery stenosis (F igure 1A). Owing to the acute onset of unstable angina and evidence of jeopardized myocardium based on serum markers and echocardiographic ndings, percutaneous coronary intervention with stent placement was performed on both lesions (F igure 1B).
F ollow-up laboratory results revealed a peak CK of 552 U=l with MB of 95.6 U=l and troponin-I greater than 50.0 ng=ml. The next morning a lipid panel revealed a total cholesterol of 201 mg=dl, triglyceride of 450 mg=dl, HDL of 19 mg=dl, LD L of 132 mg=dl, and a lipoprotein (a) level of 2 mg=dl (normal: 0¡30 mg=dl). Her hemoglobin A1C level was 6.5% (normal: 4.1¡6.0% ).
After her coronary intervention, the remaining hospitalization was uncomplicated. After ve days the patient was discharged from the hospital on labetalol, lisinopril, furosemide, aspirin, clopidogrel, atorvastatin, and her previous insulin regimen. Immunosuppressive treatment was not initiated based on the rheumatology service consultation obtained during her hospitalization. After her acute coronary event and percutaneous coronary intervention, the decision was made to aggressively treat the patient's atherosclerotic risk factors and continue antiplatelet therapy. The issue of starting immunosuppressive therapy was going to be addressed again as an outpatient. U nfortunately, since hospital discharge the patient has been lost to follow-up.
Discussion
In 1972, Sharp et al rst described MCTD as a distinct rheumatic disease with overlapping features of systemic lupus erythematosus, polymyositis, and scleroderma. 7 In addition to its rheumatic features, MCTD has a number of cardiac manifestations including pericarditis, pericardial effusion, myocarditis, ventricular hypertrophy, ventricular dilatation, cardiac conduction disturbances, and vascular intimal hyperplasia. 8¡13 In one study evaluating 38 patients with MCTD, four of the ve patients who died underwent an autopsy. All four showed epicardial and intramural coronary intimal proliferation. 13 Interestingly, none of these patients had pathologic evidence of myocardial infarction. In fact, the authors stated that there were no coronary arterial thrombi or intimal plaques to suggest atherosclerosis. In a similar follow-up study of 14 children with MCTD, arterial intimal hyperplasia and no evidence of myocardial damage was demonstrated in the two hearts undergoing autopsy. 14 F rom the original 25 patients with MCTD described by Sharp et al, a 4¡5 year follow-up study discovered that eight patients died but only one death was attributed to a myocardial infarction. 15 While arterial intimal hyperplasia is well described in patients with MCTD, the progression to an acute coronary syndrome (ACS) appears to be uncommon in the limited MCTD population described in the literature. 13¡15 D espite the lack of association between M CTD and ACS, MCTD does appear to be associated with arterial injury. Endothelin-1, a known vasoconstricting peptide, has been shown to cause endothelial damage and impair function. 16 Both endothelin-1 and cytotoxic endothelial cell antibodies have been found to be signi cantly increased in patients with MCTD and may contribute to vascular injury in M CTD. 17, 18 Interestingly, the arteriographic appearance of this patient is typical for that seen in vasculitis (F igure 1A). 3 The lesions in the left anterior descending artery and posterior lateral branch show smooth narrowing with normal-appearing arteries proximal and distal to the stenosis. All other arterial segments were normal except for a mild narrowing at the proximal left anterior descending artery which could represent early atherosclerotic plaque formation. While this case is most consistent with vasculitis, similar angiographic abnormalities are seen in the intimal variety of bromuscular dysplasia. 19 There are limited reports in the literature with regards to treating active coronary vasculitis with balloon angioplasty and stenting. Coronary interventional experience has been mostly described in Kawasaki disease and Takayasu's arteritis. 20, 21 Although the long-term outcome with both in ammatory processes is poor after balloon angioplasty alone, the incidence of restenosis and aneurysmal formation appears to be reduced after stent implantation. 20, 21 Based on a follow-up of 22 patients with Kawasaki disease who received catheter intervention for coronary lesions (seven patients with stent implantation), the rate of restenosis from both short (6 months) and long term ( 3 years) follow-up were 9% and 13% , respectively. 21 The rate of restenosis with coronary vasculitis may be even lower with the advent of glycoprotein (GP) IIb=IIIa inhibitors given as an adjunct to coronary revascularization. The administration of G PIIb=IIIa inhibitors has been shown to suppress increased levels of in ammatory markers after percutaneous coronary intervention. 22 F urther long-term studies are needed to evaluate the ef cacy of current revascularization procedures in the setting of coronary vasculitis. There are no good data on angioplasty and stenting in the presence of active vasculitis, which should be reserved for patients who present with unstable angina or acute myocardial infarction.
It appears uncommon for MCTD patients to develop an ACS. However, the teenager in this case had multiple in ammatory processes including vasculitis from MCTD and atherosclerotic risk factors including diabetes mellitus, hypertension, and dyslipidemia. Similar to vasculitis, atherosclerosis is an in ammatory process facilitated by immune processes. Whether in response to oxidized LD L in hyperlipidemics or glycosylated proteins in diabetics, T cells and macrophages activate and start a cascade of cytokines to induce in ammation. 1, 2 These same in ammatory cells are activated in rheumatic processes such as MCTD. 13, 14 M arkers such as CR P, tumor necrosis factor alpha (TNF -a), interleukin-1 and 6 (IL-1 and IL-6), and ESR have been shown to identify systemic in ammatory activity. 1, 2 As discussed previously, MCTD is associated with arterial intimal hyperplasia. Intimal hyperplasia is thought to be caused by an in ammatory mediated proliferation of smooth muscle cells and an increase in extracellular matrices. 23 In the setting of cardiovascular risk factors such as hyperlipidemia, macrophages take up lipid deposits and become foam cells. It is thought that these foam cells then secrete chemotactic factors that stimulate and recruit additional in ammatory and smooth muscle cells to the arterial wall. 23 The end result is a transformation from a hyperplastic intimal layer to an atherosclerotic plaque. Plaque vulnerability leading to ACS has been shown to be closely associated with intraplaque in ammation. 24 This is an unusual case of a teenager with M CTD and multiple cardiac risk factors presenting with a myocardial infarction. Given the extreme prematurity of her coronary event with a paucity of family cardiovascular history, typical angiographic appearance of vasculitis, and a markedly elevated sedimentation rate, her coronary lesions are likely secondary to the mixed connective tissue disease. H owever, given her underlying risk factors, one cannot rule out an atherosclerotic etiology for her CAD and an ongoing in ammatory process such as MCTD as a stimulus for plaque rupture. It is entirely possible that a combination of her underlying MCTD and atherosclerotic risk factors may have been additive and thus been responsible for her premature myocardial infarction.
